Literature DB >> 20979080

Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agents.

Raphaël Labruère1, Benoît Gautier, Marlène Testud, Johanne Seguin, Christine Lenoir, Stéphanie Desbène-Finck, Philippe Helissey, Christiane Garbay, Guy G Chabot, Michel Vidal, Sylviane Giorgi-Renault.   

Abstract

We designed and synthesized two novel series of azapodophyllotoxin analogues as potential antivascular agents. A linker was inserted between the trimethoxyphenyl ring E and the tetracyclic ABCD moiety of the 4-aza-1,2-didehydropodophyllotoxins. In the first series, the linker enables free rotation between the two moieties; in the second series, conformational restriction of the E nucleus was considered. We have identified several new compounds with inhibitory activity toward tubulin polymerization similar to that of CA-4 and colchicine, while displaying low cytotoxic activity against normal and/or cancer cells. An aminologue and a methylenic analogue were shown to disrupt endothelial cell cords on Matrigel at subtoxic concentrations, and an original assay of drug washout allowed us to demonstrate the rapid reversibility of this effect. These two new analogues are promising leads for the development of vascular-disrupting agents in the podophyllotoxin series.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20979080     DOI: 10.1002/cmdc.201000305

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  4 in total

Review 1.  Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.

Authors:  A Kumar; V Kumar; A E Alegria; S V Malhotra
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  Novel cis-selective and non-epimerisable C3 hydroxy azapodophyllotoxins targeting microtubules in cancer cells.

Authors:  Sahar Kandil; Jennifer M Wymant; Benson M Kariuki; Arwyn T Jones; Christopher McGuigan; Andrew D Westwell
Journal:  Eur J Med Chem       Date:  2015-12-23       Impact factor: 6.514

3.  Enhanced tumor homing of pathogen-mimicking liposomes driven by R848 stimulation: A new platform for synergistic oncology therapy.

Authors:  Xiaobei Cheng; Pei Yu; Xiang Zhou; Jiale Zhu; Yubao Han; Chao Zhang; Lingyi Kong
Journal:  Acta Pharm Sin B       Date:  2021-08-21       Impact factor: 11.413

4.  Synthesis and biological activity, and molecular modelling studies of potent cytotoxic podophyllotoxin-naphthoquinone compounds.

Authors:  Ha Thanh Nguyen; Quynh Giang Nguyen Thi; Thu Ha Nguyen Thi; Phuong Hoang Thi; Giang Le-Nhat-Thuy; Tuyet Anh Dang Thi; Bao Le-Quang; Hai Pham-The; Tuyen Van Nguyen
Journal:  RSC Adv       Date:  2022-08-09       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.